Rielasingen, Germany

Walter Palosch


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2008-2013

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Walter Palosch: Innovator in Pharmaceutical Processes

Introduction

Walter Palosch is a notable inventor based in Rielasingen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of roflumilast, a medication used for treating chronic obstructive pulmonary disease (COPD). With a total of 4 patents to his name, Palosch's work has had a meaningful impact on medical treatments.

Latest Patents

Palosch's latest patents focus on the preparation of roflumilast. One patent describes a composition comprising roflumilast with a purity of greater than or equal to 99% by weight, along with N-(3,5-dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-hydroxybenzamide present in a specific amount. Another patent outlines a method for treating COPD by administering a therapeutically effective amount of roflumilast, also ensuring the same high purity and specific composition.

Career Highlights

Throughout his career, Walter Palosch has worked with prominent companies in the pharmaceutical industry, including Takeda GmbH and Nycomed GmbH. His experience in these organizations has allowed him to refine his expertise in drug development and patenting processes.

Collaborations

Palosch has collaborated with several professionals in his field, including Bernhard Kohl and Bernd Mueller. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Walter Palosch is a distinguished inventor whose work in pharmaceutical processes has led to significant advancements in the treatment of COPD. His contributions through his patents and collaborations highlight his commitment to innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…